Results 31 to 40 of about 78,921 (263)
Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line
Journal of Microbiology, Immunology and Infection, 2019 Background: Cytokines and chemokines play critical roles in the pathogenesis of asthma. Azithromycin, a macrolides, is frequently used in asthmatic children with lower respiratory tract infection and is reported having anti-inflammatory and ...
Chang-Hung Kuo +4 more
doaj +1 more source
Removal of azithromycin from wastewater using advanced oxidation processes (UV/H2O2) and moving-bed biofilm reactor (MBBR) by the response surface methodology (RSM) [PDF]
Journal of Advances in Environmental Health Research, 2019 Antibiotics are among the major concerns in terms of environmental control due to their cumulative properties, adverse health effects on humans, and development of drug resistance.
Rouhollah Shokri +4 more
doaj +1 more source
Periodontology 2000, EarlyView., 2023 Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera +4 more
wiley +1 more source
Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks
Infectious Diseases of Poverty, 2022 Background Mass drug administration (MDA) is a strategy to improve health at the population level through widespread delivery of medicine in a community.
Robert J. Rolfe +2 more
doaj +1 more source
Supra and subgingival application of antiseptics or antibiotics during periodontal therapy
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases (gingivitis and periodontitis) are characterized by inflammatory processes which arise as a result of disruption of the balance in the oral ecosystem. According to the current S3 level clinical practice guidelines, therapy of patients with periodontitis involves a stepwise approach that includes the control of the patient ...
Elena Figuero +5 more
wiley +1 more source
Azithromycin (Zithromax ®) [PDF]
Infectious Diseases in Obstetrics and Gynecology, 1996 Azithromycin (Zithromax ®, Pfizer, Inc., New York, NY) is a 15‐membered‐ring macrolide and the first azalide antibiotic. It is distinguished from other macrolides by its rapid and extensive penetration into intracellular and interstitial tissue compartments, accompanied by prolonged tissue and serum half‐lives.
openaire +2 more sources
Microbiology SpectrumThe latest guidelines include azithromycin as a preferred regimen for treating Mycobacterium avium complex (MAC) pulmonary disease. However, serially collected susceptibility data on clinical MAC isolates are limited, and no breakpoints have been ...
Yoshifumi Uwamino +8 more
doaj +1 more source
Pakistan Journal of Pharmaceutical SciencesAzithromycin is a member of macrolide antibiotics, and has been reported to inhibit the proliferation of cancer cells. Nanoparticles particularly nanometals have been recently investigated in cancer chemotherapy owing to their enhanced pharmacokinetic ...
Dabeeran Zehra +6 more
doaj +1 more source
Frontiers in Microbiology, 2016 S. suis (Streptococcus suis) caused serious disease symptoms in humans and pigs. S. suis is able to form thick biofilms and this increases the difficulty of treatment.
Yanbei Yang +8 more
doaj +1 more source
Safety of azithromycin in infants under six months of age in Niger: A community randomized trial. [PDF]
PLoS Neglected Tropical Diseases, 2018 BACKGROUND:Mass azithromycin distribution reduces under-5 child mortality. Trachoma control programs currently treat infants aged 6 months and older. Here, we report findings from an infant adverse event survey in 1-5 month olds who received azithromycin
Catherine E Oldenburg +14 more
doaj +1 more source